Results 111 to 120 of about 3,160 (157)

Treatment of an Aggressive Gonadotroph Pituitary Neuroendocrine Tumor With ¹⁷⁷Lutetium DOTATATE Radionuclide Therapy. [PDF]

JCEM Case Rep
Gandhi C, Koumna S, Chik C.
europepmc   +1 more source

The neuroscience of cancer: Focus on neuropeptidergic systems. [PDF]

Acta Pharm Sin B
Dong Z, Wang Y, Jin W.
europepmc   +1 more source

Quantitative 177Lu-DOTATATE SPECT/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study. [PDF]

EJNMMI Res
Megherbi I, Hoog C, Perrier M, Brixi H, Cadiot G, Hoeffel-Fornes C, Morland D.   +6 more
europepmc   +1 more source

The use of tissue fiducial markers in improving the accuracy of post-prostatectomy radiotherapy. [PDF]

Radiat Oncol J, 2019
Chao M, Ho H, Joon DL, Chan Y, Spencer S, Ng M, Wasiak J, Lawrentschuk N, McMillan K, Sengupta S, Tan A, Koufogiannis G, Cokelek M, Foroudi F, Khong TS, Bolton D.   +15 more
europepmc   +1 more source

Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [¹⁷⁷Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine. [PDF]

J Nucl Med
Hebert K, Santoro L, Monnier M, Castan F, Berkane I, Assénat E, Fersing C, Gélibert P, Pouget JP, Bardiès M, Kotzki PO, Deshayes E.   +11 more
europepmc   +1 more source

The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy. [PDF]

J Nucl Med
Yadav S, Lawhn-Heath C, Paciorek A, Lindsay S, Mirro R, Bergsland EK, Hope TA.   +6 more
europepmc   +1 more source

Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients. [PDF]

Oncologist
Ladekarl M, Mørk ML, Albertsen ES, Nielsen D, Lassen U, Mau-Sørensen M, Nielsen CM, Jakobsen A, von der Maase H.   +8 more
europepmc   +1 more source

LES PPRT DANS LE DUNKERQUOIS : DES ARTIFICES D’UNE CONCERTATION OBLIGÉE À LA CONSTRUCTION DE COMPROMIS

, 2013
Grembo, Nicolas, Le Blanc, Antoine, Gibout, Christophe, Zwarterook, Irénée, Calvo-Mendieta, Iratxe, Chambon, Mylène, Flanquart, Hervé, Frère, Séverine   +7 more
openaire   +1 more source

Multiomics Mendelian randomization integrating pQTL, eQTL and mQTL data revealed BTN3A2 as a potential drug target for nephrolithiasis. [PDF]

Sci Rep
Sun S, Wang Y, Dong Q, Bi J, Fu Y.
europepmc   +1 more source

Rare but not forgotten: Therapeutic advancements for rare childhood cancers. [PDF]

Mol Ther Oncol
Crane JN, Dagalakis U, Gartrell RD, Schultz KAP, Laetsch TW.   +4 more
europepmc   +1 more source